Synthetic Hydrogels for Organogenesis with Tunable Biodegradable Polymers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Natural hydrogels like MATRIGEL introduce immunogenic and pathogenic risks, batch-to-batch variability, and unclear biological roles, limiting the development of human organoids and organogenesis, especially from postnatal biopsied cells.
Innovation Solution
Development of synthetic hydrogels with tunable biodegradable polymers and specific binders, such as polyethylene glycols and integrin-binding peptides, to control cell-matrix interactions, providing a defined matrix for organoid growth and overcoming limitations of natural hydrogels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If natural hydrogels like MATRIGEL are used as 3D scaffold for organoid growth, then organoid formation is supported, but immunogenic and pathogenic risks are introduced
Solution Approach 1:
The patent creates a synthetic hydrogel that copies the essential functional properties of natural MATRIGEL scaffold (3D structure, cell adhesion support, organoid formation capability) while using fully synthetic polymers (PEG, PCL, PLA) instead of animal-derived materials, thereby eliminating immunogenic and pathogenic risks while maintaining organoid formation support
Solution Approach 2:
The patent systematically varies the molecular weight, ratio, and composition of synthetic polymer components (PEG, PCL, PLA) to tune the physical and biological properties of the hydrogel, achieving MATRIGEL-like functionality with controllable degradation rates, mechanical properties, and cell-matrix interactions without using natural materials
2Reliability
If MATRIGEL is used as scaffold, then organoid growth is enabled, but batch-to-batch variability occurs
Solution Approach 1:
The patent uses fully synthetic polymers with precisely controlled molecular weights (e.g., PEG 2kDa, 4kDa, 10kDa; PCL 84kDa; PLA 100kDa) and defined ratios (e.g., PEG:PCL:PLA = 6:3:1) that can be consistently manufactured, eliminating the batch-to-batch variability inherent in natural MATRIGEL extraction processes while maintaining organoid growth support
Solution Approach 2:
The synthetic hydrogel replicates the essential functional characteristics of MATRIGEL (3D porous structure, cell adhesion ligands, appropriate mechanical stiffness) through controlled synthesis of polymer blends, ensuring consistent composition and performance across batches without relying on natural material variability
3Reliability
If MATRIGEL is used for organoid culture, then 3D scaffold function is provided, but the role of ECM factors cannot be manipulated
Solution Approach 1:
The patent divides the ECM functionality into separate controllable components: synthetic polymer matrix (PEG/PCL/PLA) providing structural scaffold, and separately incorporated cell-adhesive peptides (RGD, GFOGER, PHSRN) that can be independently optimized and manipulated to study specific ECM factor roles without the complexity of natural ECM mixtures
4Reliability
If MATRIGEL is used as scaffold, then organoid growth is supported, but cumbersome removal process is required
Solution Approach 1:
The patent designs the synthetic hydrogel with temperature-responsive or enzyme-cleavable crosslinking mechanisms that allow the scaffold to transition from a stable gel state during culture to a soluble or degradable state for easy organoid recovery, eliminating the cumbersome mechanical removal process required for MATRIGEL
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The synthetic hydrogels support the growth of human organoids with controlled cell-matrix interactions, reducing variability and immunogenic risks, and allowing for precise tuning of biomechanical and biological properties, enhancing the reliability and scalability of organoid cultures.
Implementation Method 1
Synthetic hydrogels for organogenesis from mammalian cells, preferably biopsied human cells, and especially epithelial cells, have been developed
Implementation Method 2
The synthetic hydrogels typically include a plurality of biodegradable polymers and one or more binders
Implementation Method 3
The biodegradable polymers can be one or more polyalkylene glycols, preferably polyethylene glycols
Data Source
AI summary
Synthetic hydrogels for organogenesis support organogenesis from mammalian cells, including human cells. The synthetic hydrogels typically include a network of crosslinked branched biodegradable polymers. A portion of the branches of the branched biodegradable polymers are linked to binders which are generally synthetic peptides for cell and extracellular matrix attachment. The hydrogels may include an inhibitor of apoptosis. The synthetic hydrogels with the synthetic binders typically do not interfere with cellular, proteomic, genetic, and/or transcriptome analyses of organoids formed in the hydrogel. The synthetic hydrogels may be subject to on-demand dissolution to provide intact organoids substantially free of hydrogel polymers. Also provided are methods of making the synthetic hydrogels and methods of using the synthetic hydrogels for organogenesis.